Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Allen Wolff Insider Profile
4 Followers
Allen Wolff, Former Director and CEO, Director at Eterna Therapeutics, holds 132.72K shares in Eterna Therapeutics (Ticker: ERNA).
Allen Wolff Eterna Therapeutics (ERNA)Former Director and CEO, Director
Eterna Therapeutics (ERNA)
Former Director and CEO, Director
Ranked #74,290 out of 98,042 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-24.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
Former Director and CEO, Director
Roles that Allen Wolff holds in companies
Most Profitable Insider Trade
The most profitable trade made by Allen Wolff
Allen Wolff's Trading History
List of latest transactions for each holding click on a transaction to see Allen Wolff's performance on stock
You May Also Like
Allen Wolff insider profile FAQ
What is the percentage of profitable transactions made by Allen Wolff?
The percentage of profitable transactions made by Allen Wolff is 33%.
What is the average return per transaction made by Allen Wolff?
The average return per transaction made by Allen Wolff is -24.00%.
What stocks does Allen Wolff hold?
Allen Wolff holds: ERNA stocks.
What was Allen Wolff’s latest transaction?
Allen Wolff latest transaction was an Uninformative Sell of $26.55K.
What was Allen Wolff's most profitable transaction?
Allen Wolff’s most profitable transaction was an Informative Buy of ERNA stock on June 14, 2016. The return on the trade was 1.50%.
What is Allen Wolff's role in Eterna Therapeutics?
Allen Wolff's role in Eterna Therapeutics is Former Director and CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.